<DOC>
	<DOCNO>NCT02726490</DOCNO>
	<brief_summary>A randomized comparison glyburide glucovance ( metformin -glyburide ) management diabetes pregnancy .</brief_summary>
	<brief_title>Glyburide v Glucovance Treatment GDM</brief_title>
	<detailed_description>This study randomize open label trial glyburide compare glucovance management gestational diabetes . We hypothesize glucovance provide improve glycemic control lower failure rate increase neonatal adverse outcome . Sixty-seven patient randomize computer arm study . Outcomes glycemic control , failure rate drug achieve glycemic goal , neonatal outcome .</detailed_description>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Glyburide</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Gestational diabetes Pregnancy &gt; 12 week gestation Ability give consent Inability consent study Preexisting diabetes Glucose6phosphate dehydrogenase ( G6PD ) deficiency Serum creatinine &gt; 1 Liver disease Allergy sulfa ; Allergy glyburide ; Allergy metformin ; Fetal anomaly</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>gestational diabetes , pregnancy , diabetes</keyword>
</DOC>